# OpenWhistle returns to current directory comparisons

> Public pages and pricing were accessible again in the October check, reversing the directory's earlier availability exclusion.

Canonical: https://whistleblowertools.eu/journal/openwhistle-public-site-recovered/
Last updated: 2026-10-18

[OpenWhistle's](https://whistleblowertools.eu/tools/openwhistle/) five cited public pages were accessible during the **18 October 2026** source review. A browser check also recovered the published pricing. The directory removed the earlier availability exclusion, which had followed an HTTP 526 error.

## What we could verify again

The public offer showed **EUR 22/month**, or **EUR 211.20/year**, described as a 20% annual saving. The annual amount is equivalent to **EUR 17.60/month**. VAT is additional, and the price is per organisation with unlimited users. The published calls to action led to a demo request.

![OpenWhistle public pricing page showing its subscription offer](https://whistleblowertools.eu/evidence/2026-10-18/openwhistle-pricing.png)

The public offer was accessible when the journal evidence was captured. Captured: 2026-10-18T13:45:50.316Z. Source: https://openwhistle.pt/en/

## Why the directory changed

The recovered product and pricing pages provide a current public offer to evaluate. OpenWhistle therefore returns to current directory comparisons.

This is also why availability findings need follow-up: an earlier failure should not remain a permanent exclusion after contrary evidence is available. The recovery receives a dated entry just as the problem did.

## Limits of the check

We did not establish when the website recovered or how long the earlier problem lasted. No account was created, no report was submitted and no handler environment was tested. This source refresh does not establish uninterrupted service, report delivery or a new product-test score.

The [current profile](https://whistleblowertools.eu/tools/openwhistle/) retains the distinction between its public-source refresh and the earlier review of product evidence.